DoveMed.com

Solitary Fibrous Tumor of Breast

Article
Women's Health
Diseases & Conditions
+2
Contributed byKrish Tangella MD, MBAMar 28, 2018

What are the other Names for this Condition? (Also known as/Synonyms)

  • Breast SFT
  • Breast Solitary Fibrous Tumor
  • SFT of Breast 

What is Solitary Fibrous Tumor? (Definition/Background Information)

  • Solitary Fibrous Tumor (SFT) of Breast is a mostly benign (non-cancerous) overgrowth arising from mesenchymal tissue
  • The mesenchyme is the middle layer of the 3 primary germ layers of an embryo, namely the ectoderm, mesoderm, and endoderm. The mesoderm gives rise to mesenchymal tissue, which is the source for bone, muscle, connective tissue, and dermis of skin
  • Solitary Fibrous Tumors are composed of fibroblasts and related cell types. These rare tumors can occur in any part of the body, or in the soft tissues, where mesenchymal cells are present. The tumor arises in the breast as a firm mass
  • The cause of formation of the tumor is unknown and currently, no known methods exist to prevent occurrence of the tumor
  • Most small tumors are asymptomatic, though the larger ones may compress the surrounding structures and cause related signs and symptoms. The diagnosis of Solitary Fibrous Tumor of Breast can be confirmed through a tissue biopsy
  • The treatment is complete surgical removal of the tumor with adequate margins. Most Solitary Fibrous Tumors of Breast are benign, however some show malignant behavior in terms of recurrence of the tumor after surgery, or metastasis (spread to distant parts of the body)
  • The prognosis of Solitary Fibrous Tumor of Breast is dependent on whether the tumor can be completely removed through surgery or not

Who gets Solitary Fibrous Tumor? (Age and Sex Distribution)

  • The Solitary Fibrous Tumor of Breast can present be in individuals between 20 and 70 years of age, but is usually diagnosed in the fifth decade (between 40-50 years)
  • In general, both men and women can get it
  • Though it is a rare tumor, it can occur worldwide and all races and ethnic groups may be affected

What are the Risk Factors for Solitary Fibrous Tumor? (Predisposing Factors)

  • No clear-cut risk factors for Solitary Fibrous Tumor of Breast have been established to date

It is important to note that having a risk factor does not mean that one will get the condition. A risk factor increases ones chances of getting a condition compared to an individual without the risk factors. Some risk factors are more important than others.

Also, not having a risk factor does not mean that an individual will not get the condition. It is always important to discuss the effect of risk factors with your healthcare provider.

What are the Causes of Solitary Fibrous Tumor? (Etiology)

  • Currently, scientists do not know the factor(s) causing Solitary Fibrous Tumor of Breast
  • As with other tumor types, SFT of Breast begins when normal, healthy cells, transform into abnormal ones, which then begin to grow and multiply
  • These cells can lead to the formation of masses or tumors, which may even spread (metastasize) outside the breast (like to the lymph nodes)
  • Certain genetic mutations are have been detected. Research to characterize these mutations is currently underway

What are the Signs and Symptoms of Solitary Fibrous Tumor?

The signs and symptoms depend on the size of the tumor. Solitary Fibrous Tumors can range in size from a few cm to up to 40 cm. Majority of the breast tumors are less than 10 cm. They are usually slow-growing and form a single mass. The signs and symptoms associated with Solitary Fibrous Tumor of Breast include:

  • Small tumors usually do not cause any symptoms. But, occasionally they may become painful, if they compress surrounding structure
  • A lump in the breast, or underarm area
  • Thickening or swelling of part of the breast; change in the size or shape of the breast
  • The tumors may present as slowly enlarging painless mass, which occurs in the breast
  • Breast pain may occur in rare cases
  • Rarely, these tumors, especially if large, may cause hypoglycemia
    • Hypoglycemia results in Doege-Potter syndrome, which occurs due to secretion of insulin-like growth factor-2 (IGF-2) by the tumor cells (paraneoplastic syndrome)
    • The signs and symptoms of hypoglycemia include confusion, altered mental status, sweating, dizziness, cold hands, etc.

How is Solitary Fibrous Tumor Diagnosed?

The following procedures and tools may be used in the diagnosis of Solitary Fibrous Tumor of Breast:

  • Evaluation of the individual’s medical history and a through physical examination
  • Breast exam: The physician will check for any lumps or unusual signs, in the breasts
  • Mammogram: A mammogram uses x-rays to provide images of the breast. Screening mammograms are commonly used to detect possible signs of breast tumor, in women with no apparent symptoms. Diagnostic mammograms give more detailed images of areas in the breast, after abnormalities have been detected using a screening mammogram
  • Breast ultrasound: This technique uses high-frequency sound waves to produce images of the breast. An ultrasound can help identify whether a lump is a fluid-filled cyst (non-cancerous) or a solid mass (which may be cancerous or benign)
  • Plain x-ray of the chest
  • CT or CAT scan with contrast of the chest usually shows a well-defined mass, which may have calcifications. This radiological procedure creates detailed 3-dimensional images of structures inside the body
  • MRI scans of the breast and lungs: Magnetic resonance imaging (MRI) uses a magnetic field to create high-quality pictures of certain parts of the body, such as tissues, muscles, nerves, and bones. These high-quality pictures may reveal the presence of the tumor
  • Solitary Fibrous Tumor of Breast can additionally be evaluated using angiography
  • MRI scans and PET scans may help differentiate benign versus malignant SFTs by detecting areas of metastasis (if any)

Although the above modalities can be used to make an initial diagnosis, a tissue biopsy of the tumor is necessary to make a definitive diagnosis to begin treatment. The tissue for diagnosis can be procured in multiple different ways which include: 

  • Fine needle aspiration (FNA) biopsy of the tumor: A FNA biopsy may not be helpful, because one may not be able to visualize the different morphological areas of the tumor. Hence, a FNA biopsy as a diagnostic tool has certain limitations, and an open surgical biopsy is preferred. Also, SFT is a fibrous tumor and FNA usually does not reveal many cells on microscopic examination
  • Breast core biopsy of the tumor
  • Breast open biopsy of the tumor

Tissue biopsy:

  • A tissue biopsy of the tumor is performed and sent to a laboratory for a pathological examination. A pathologist examines the biopsy under a microscope. After putting together clinical findings, special studies on tissues (if needed) and with microscope findings, the pathologist arrives at a definitive diagnosis. Examination of the biopsy under a microscope by a pathologist is considered to be gold standard in arriving at a conclusive diagnosis
  • Biopsy specimens are studied initially using Hematoxylin and Eosin staining. The pathologist then decides on additional studies depending on the clinical situation
  • Sometimes, the pathologist may perform special studies, which may include immunohistochemical stains, molecular testing, and very rarely, electron microscopic studies to assist in the diagnosis

Many clinical conditions may have similar signs and symptoms. Your healthcare provider may perform additional tests to rule out other clinical conditions to arrive at a definitive diagnosis.

What are the possible Complications of Solitary Fibrous Tumor?

Complications due to Solitary Fibrous Tumor of Breast could include:

  • Hypoglycemia resulting in Doege-Potter syndrome, which occurs due to secretion of insulin-like growth factor-2 (IGF-2) by the tumor cells
  • Recurrence of SFT following surgery
  • Malignant transformation resulting in metastatic SFT
  • Complications may arise during chemotherapy and radiation therapy, due to the toxic medication or radiation effect

How is Solitary Fibrous Tumor Treated?

There is no standard treatment protocol established for Solitary Fibrous Tumor of Breast. However, in majority of cases, a complete surgical excision with clear or wide margins is the preferred mode of treatment, which can result in a cure, especially if it behaves in a benign manner. They are surgically removed with wide margins.

Possible treatment measures for Solitary Fibrous Tumor of Breast include the following:

  • Lumpectomy: Breast-sparing surgery (least invasive breast cancer surgery) in which the tumor, as well as a small portion of the surrounding tissue, is removed
  • Mastectomy: Surgery to remove all of the breast tissue; it may be simple (removal of the breast, nipple, areola, sentinel lymph nodes) or radical mastectomy (removal of the breast, nipple, areola, all axillary lymph nodes, and underlying muscle of the chest wall)
  • Long-term follow-up is required, because recurrence at the site of surgery or metastasis in distant sites have been reported many years after surgery, even with tumors that behave benignly
  • Radiotherapy can be used as primary therapy in situations where the tumor cannot be removed completely, or when the tumor reappears (recurrent Solitary Fibrous Tumor of Breast) after surgery
  • Radiotherapy for SFT can also be used as additional therapy after surgery, if there is a possibility of tumor recurrence after surgery, or if there are inadequate margins (possibility of tumor left behind) following surgery. In some cases due to location of tumor, a complete surgical removal of the tumor is difficult
  • Chemotherapy can be used for treating Solitary Fibrous Tumor of Breast in following conditions:
    • When the tumors cannot be removed completely (due to incomplete surgical resection)
    • Tumors that recur after surgery (recurrent SFT of Breast)
    • Tumors that have spread to distant parts of the body (metastatic SFT of Breast)
  • Arterial embolization is a possible treatment option. Here the blood supply to the tumor is blocked resulting in tumor death
  • Hypoglycemia due to the tumor is treated using corticosteroids
  • Post-operative care is important: One must maintain minimum activity levels, until the surgical wound heals

How can Solitary Fibrous Tumor be Prevented?

  • Current medical research has not established a way of preventing Solitary Fibrous Tumor of Breast formation
  • Regular medical screening at periodic intervals with blood tests, radiological scans, and physical examinations, for those who have already endured the tumor, are helpful

What is the Prognosis of Solitary Fibrous Tumor? (Outcomes/Resolutions)

  • The most reliable prognostic factor of Solitary Fibrous Tumor of Breast is dependent on whether the tumor can be completely removed through surgery with free margins (no traces of the tumor in adjoining tissue) or not
  • Current studies show that the tumor does not have any specific histologic feature (when a pathologist examines the tissue under a microscope), which can help in assessing a definite prognosis for the tumor
  • Individuals have an overall excellent survival rate following first complete surgical resection
  • Solitary Fibrous Tumor of Breast that behave malignantly can lead to death
  • As with any tumor, it is important to have follow-up appointments with a physician to monitor for any returning tumors

The prognosis of Solitary Fibrous Tumors also depends upon a set of several factors, which include:

  • Stage of tumor: With lower-stage tumors, when the tumor is confined to site of origin, the prognosis is usually excellent with appropriate therapy. In higher-stage tumors, such as tumors with metastasis, the prognosis is poor
  • The surgical respectability of the tumor (meaning, if the tumor can be removed completely) 
  • Overall health of the individual: Individuals with overall excellent health have better prognosis compared with those with poor health
  • Age of the individual: Older individuals generally have poorer prognosis than younger individuals
  • Whether the tumor is occurring for the first time, or is a recurrent tumor. Recurring tumors have worse prognosis compared to tumors that do not recur
  • Response to treatment: Tumors that respond to treatment have better prognosis compared to tumors that do not respond to treatment

An early diagnosis and prompt treatment of the tumor generally yields better outcomes than a late diagnosis and delayed treatment.

Additional and Relevant Useful Information for Solitary Fibrous Tumor:

  • A tumor is an abnormal growth of tissue arising due to uncontrolled and rapid multiplication of cells that serve no function. They are also called neoplasms. Tumors can be benign or cancerous. A benign tumor may generally indicate no threat to one’s health; it also means that it is not “cancerous”
  • Grossly, Solitary Fibrous Tumor of Breast is well-circumscribed but not encapsulated, and on cross-section appears gray white to yellow white in color
  • Microscopically, benign SFT exhibit alternation of hyper- and hypo- cellular areas, patternless pattern, keloid type collagen, and staghorn-shaped vessels-like areas
  • A pathologist may use special studies such as special stains. Special stains (markers) used on biopsy samples may include CD34, CD99, Vimentin, BCL-2. These stains help differentiate Solitary Fibrous Tumors of Breast from other benign or cancer lesions
  • Although Solitary Fibrous Tumor can be classified as malignant based on the biopsy study (tumor greater than 5 cm, increased mitotic rate, necrosis, increased cellularity, or cytologic atypia, infiltrative growth, and weak CD34), these features cannot be absolutely correlated with regards to how it behaves, the nature of which may be aggressive, metastasis, or recurrent
  • Basic fibroblast growth factor (bFGF) labeling index and Ki-67 labeling index can be used for evaluation of benign versus malignant Solitary Fibrous Tumors of Breast
  • Hemangiopericytoma (also known as Solitary Fibrous Tumor - Hemangiopericytoma type; or Cellular Solitary Fibrous Tumor) is closely related to SFT of Breast, but is not identical to it. Many pathologists consider hemangiopericytoma and Solitary Fibrous Tumor as a continuum of tumors
Was this article helpful

On the Article

Krish Tangella MD, MBA picture
Approved by

Krish Tangella MD, MBA

Pathology, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!